The Enhanced Liver Fibrosis Test is a Superior Blood-Based Predictor of Advanced Fibrosis in NAFLD patients < 65 years with Type II Diabetes

Should We Consider Using Aspirin in Patients with MASLD?

September 30, 2025

Aldafermin for the Management of Compensated MASH Cirrhosis: the ALPINE-4 Trial

February 9, 2024

Liver stiffness not steatotic liver disease is associated with atrial fibrillation

November 8, 2023